Fig. 3

Influences of miR-325-3p dysregulation on the cardiac function parameters in MI mice. a, b The comparison of LVEDD and LVESD between the sham group, MI group, MI + agomiR-control group, MI + agomiR-325-3p group and MI + antagomiR-325-3p group mice. c, d The comparison of LVEF and LVFS between the sham group, MI group, MI + agomiR-control group, MI + agomiR-325-3p group and MI + antagomiR-325-3p group mice. **P < 0.01 compared to the mice that received the sham operation, ^##P < 0.01 compared to MI mice. MI, myocardial infarction; agomiR-325-3p, miR-325-3p agomir; antagomiR-325-3p, miR-325-3p antagomir; agomiR-control, scrambled agomir or antagomir control; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; LVEF, left ventricular ejection fraction; LVES, left ventricular fractional shortening